HOME-USE HIV TEST SAMPLE COLLECTION KITS: FDA EVALUATION POLICY
This article was originally published in The Tan Sheet
Executive Summary
HOME-USE HIV TEST SAMPLE COLLECTION KITS: FDA EVALUATION POLICY will be reviewed by the agency's Blood Products Advisory Panel at a June 22 meeting. In a June 9 Federal Register notice announcing changes to the panel's agenda for its June 21-22 meeting; FDA said it will "reexamine the approach described" in earlier policy statements published in 1989 and 1990 "to evaluate the safety and effectiveness of [sample] collection kits," specifically those used for detecting HIV infection.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning